Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.690
+0.110 (3.07%)
At close: Mar 31, 2026, 4:00 PM EDT
3.960
+0.270 (7.32%)
After-hours: Mar 31, 2026, 5:52 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Surgical Aesthetics
45.33M38.61M43.38M36.80M42.99M
Surgical Aesthetics Growth
17.42%-11.01%17.88%-14.38%93.50%
Original Equipment Manufacturing (OEM)
7.51M9.50M8.97M7.71M5.53M
Original Equipment Manufacturing (OEM) Growth
-20.89%5.90%16.35%39.32%0.64%
Total
52.84M48.10M52.35M44.51M48.52M
Total Growth
9.86%-8.11%17.61%-8.26%75.08%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
38.80M34.02M38.35M31.21M32.98M
United States Growth
14.05%-11.27%22.87%-5.37%75.31%
International
14.04M14.08M14.00M13.30M15.54M
International Growth
-0.26%0.54%5.28%-14.39%74.59%
Total
52.84M48.10M52.35M44.51M48.52M
Total Growth
9.86%-8.11%17.61%-8.26%75.08%
Source: S&P Global Market Intelligence.